A61K 38/2257
Prolactin
Official title: {Prolactin}
A61K38/2257 (Prolactin) appears on 64 US grants and 65 published applications in this corpus.
Search patents in A61K- Granted patents
- 64
- Published applications
- 65
- Assignees
- 45
- Inventors
- 90
- Latest grant
- 4 Mar 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 3 | 0 |
| 1997 | 10 | 0 |
| 1998 | 13 | 0 |
| 1999 | 5 | 0 |
| 2000 | 2 | 0 |
| 2001 | 0 | 1 |
| 2002 | 0 | 2 |
| 2003 | 0 | 7 |
| 2004 | 0 | 1 |
| 2005 | 0 | 4 |
| 2006 | 4 | 5 |
| 2007 | 1 | 3 |
| 2008 | 1 | 4 |
| 2009 | 2 | 3 |
| 2010 | 2 | 4 |
| 2011 | 3 | 6 |
| 2012 | 2 | 7 |
| 2013 | 3 | 3 |
| 2014 | 4 | 1 |
| 2015 | 1 | 2 |
| 2016 | 2 | 3 |
| 2017 | 0 | 2 |
| 2018 | 1 | 0 |
| 2019 | 0 | 2 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 3 |
By publication year. Applications have been published since 2001.
Recent patents
- Method and system for tuning hormone receptors through the dynamic intravenous delivery of a hormone according to a target physiological cadence4 Mar 2025US 12,239,690 B1Well Cell Global LLC
- Lipidated peptides as anti-obesity agents10 Apr 2018US 9,937,235 B2Ustav Organicke Chemie A Biochemie Akademie Ved Cr, V. V. I.
- Method for treating breast cancer with prolactin receptor agonists21 Jun 2016US 9,370,554 B2Orbis Health Solutions LLC
- Taxane- and taxoid-protein compositions10 May 2016US 9,333,189 B2OncBioMune, L.L.C.
- Viral vector encoding a toll-like receptor and encoding a toll-like receptor agonist8 Dec 2015US 9,205,095 B2Panacela Labs, Inc.
- Method and System for Tuning Hormone Receptors through the Dynamic Intravenous Delivery of a Hormone According to a Target Physiological Cadence11 Dec 2025US 2025/0375503 A1Well Cell Global LLC
- Compositions for treating inflammatory airway disease and uses thereof14 Aug 2025US 2025/0255934 A1Lateral IP Pty Ltd
- Neuroprotective compositions and use thereof13 Feb 2025US 2025/0049889 A1NanoNeuron Therapeutics, Inc.
- Peptides and uses thereof10 Nov 2022US 2022/0354929 A1Lateral IP Pty Ltd
- Neuroprotective compositions and use thereof30 Sep 2021US 2021/0299218 A1NanoNeuron Therapeutics, Inc.
Most cited
By later US patents
- Process for the preparation of microspheres made of a biodegradable polymeric material93US 5,445,832 ADebio Recherche Pharmaceutique S. A. · 1995
- Compositions and methods for treating exocrine gland atrophy91US 5,639,743 AUniversity of Georgia Research Foundation, Inc. · 1997
- Method for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates66US 5,344,832 AErgo Science Incorporated · 1994
- Therapeutic process for the treatment of the pathologies of Type II diabetes62US 5,468,755 ABoard of Supervisors of Louisiana State University and Agricultural and Mechanical College · 1995
- Therapeutic process for the treatment of the pathologies of type II diabetes60US 5,866,584 ABoard of Supervisors of Louisiana State University and Agricultural and Mechanical College · 1999